415 CAPITAL is a specialist VC that invests in early- and development-stage medical technology companies in Europe, Israel and the US.
Business Model:
Revenue: $2.4B
Employees: 0-0
Address: Bahnhofstr. 32
City: Oberhaching
State: bavaria
Zip: 82041
Country: DE
415 CAPITAL is a specialist venture capital firm that invests in early- and development-stage MedTech companies in Europe, the United States and Israel.They primarily invest in innovative medical device technologies addressing cardiovascular disease: the worldwide leading cause of death and the single largest cost driver in the global healthcare system.We are investors AND entrepreneurs: As investors, They have funded 45 MedTech companies in the past 28 years. As entrepreneurs, They have founded, built, and exited several successful European MedTech distribution companies.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
11/2021 | Aktiia | Series A | 17.5M |
2/2022 | Supira Medical | Series C | 0 |
6/2021 | Cardiac Success | Series A | 5.2M |
10/2020 | R3 Vascular Inc. | Series A | 17.8M |
3/2021 | CorFlow Therapeutics AG | Series A | 8.7M |
1/2022 | Distalmotion | Series E | 0 |
9/2022 | Tricares | Series C | 0 |
3/2020 | Supira Medical | Series B | 0 |
4/2021 | Moray Medical | Seed Round | 0 |
2/2022 | Supira Medical | Series C | 0 |
1/2022 | Distalmotion | Series E | 0 |
11/2021 | Aktiia | Series A | 0 |
6/2021 | Cardiac Success | Series A | 0 |
4/2021 | Moray Medical | Seed Round | 0 |
3/2021 | CorFlow Therapeutics AG | Series A | 0 |
10/2020 | R3 Vascular Inc. | Series A | 0 |
3/2020 | Supira Medical | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|